Kailera Therapeutics: Insider Ownership Change Reported
Ticker: KLRA · Form: 4 · Filed: Apr 20, 2026 · CIK: 0002096997
Sentiment: neutral
Topics: insider-filing, ownership-change
TL;DR
Kaplan updated ownership at Kailera. Check the details.
AI Summary
On April 16, 2026, Andrew T. Kaplan, a reporting person associated with Kailera Therapeutics, Inc., reported a change in beneficial ownership of securities. The filing details transactions related to his holdings in the company.
Why It Matters
This filing indicates a change in the beneficial ownership of securities by an insider, which can provide insights into the insider's confidence in the company's future prospects.
Risk Assessment
Risk Level: low — Form 4 filings typically report routine changes in beneficial ownership and do not inherently signal significant risk.
Key Players & Entities
- Kailera Therapeutics, Inc. (company) — Issuer
- Andrew T. Kaplan (person) — Reporting Person
- 0002096997 (company) — Kailera Therapeutics CIK
- 0001752059 (person) — Andrew T. Kaplan CIK
FAQ
What type of form was filed?
A Form 4 - Statement of changes in beneficial ownership of securities was filed.
Who is the reporting person?
Andrew T. Kaplan is the reporting person.
What is the issuer's name?
The issuer is Kailera Therapeutics, Inc.
When was the period of report?
The period of report was 2026-04-16.
What is the company's SIC code?
The company's SIC code is 2834 for Pharmaceutical Preparations.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 20, 2026 by Andrew T. Kaplan regarding Kailera Therapeutics, Inc. (KLRA). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.